Lifeline Biotechnologies' market value is the price at which a share of Lifeline Biotechnologies trades on a public exchange. It measures the collective expectations of Lifeline Biotechnologies investors about its performance. Lifeline Biotechnologies is selling at 7.0E-4 as of the 26th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 7.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Lifeline Biotechnologies and determine expected loss or profit from investing in Lifeline Biotechnologies over a given investment horizon. Check out Lifeline Biotechnologies Correlation, Lifeline Biotechnologies Volatility and Lifeline Biotechnologies Alpha and Beta module to complement your research on Lifeline Biotechnologies.
Please note, there is a significant difference between Lifeline Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifeline Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifeline Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lifeline Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lifeline Biotechnologies' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lifeline Biotechnologies.
0.00
10/28/2025
No Change 0.00
0.0
In 3 months and 1 day
01/26/2026
0.00
If you would invest 0.00 in Lifeline Biotechnologies on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Lifeline Biotechnologies or generate 0.0% return on investment in Lifeline Biotechnologies over 90 days. Lifeline Biotechnologies is related to or competes with Talis Biomedical, and USA Equities. Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lifeline Biotechnologies' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lifeline Biotechnologies upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifeline Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lifeline Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Lifeline Biotechnologies historical prices to predict the future Lifeline Biotechnologies' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lifeline Biotechnologies. Your research has to be compared to or analyzed against Lifeline Biotechnologies' peers to derive any actionable benefits. When done correctly, Lifeline Biotechnologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Lifeline Biotechnologies.
Lifeline Biotechnologies January 26, 2026 Technical Indicators
Lifeline Biotechnologies appears to be out of control, given 3 months investment horizon. Lifeline Biotechnologies has Sharpe Ratio of 0.0403, which conveys that the firm had a 0.0403 % return per unit of risk over the last 3 months. By analyzing Lifeline Biotechnologies' technical indicators, you can evaluate if the expected return of 0.58% is justified by implied risk. Please exercise Lifeline Biotechnologies' Downside Deviation of 21.36, risk adjusted performance of 0.0531, and Mean Deviation of 9.69 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lifeline Biotechnologies holds a performance score of 3. The company secures a Beta (Market Risk) of -1.57, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Lifeline Biotechnologies are expected to decrease by larger amounts. On the other hand, during market turmoil, Lifeline Biotechnologies is expected to outperform it. Please check Lifeline Biotechnologies' total risk alpha, as well as the relationship between the potential upside and kurtosis , to make a quick decision on whether Lifeline Biotechnologies' current price movements will revert.
Auto-correlation
0.12
Insignificant predictability
Lifeline Biotechnologies has insignificant predictability. Overlapping area represents the amount of predictability between Lifeline Biotechnologies time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lifeline Biotechnologies price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Lifeline Biotechnologies price fluctuation can be explain by its past prices.
Correlation Coefficient
0.12
Spearman Rank Test
-0.3
Residual Average
0.0
Price Variance
0.0
Pair Trading with Lifeline Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifeline Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Lifeline Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifeline Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifeline Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifeline Biotechnologies to buy it.
The correlation of Lifeline Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifeline Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifeline Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifeline Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.